US2012277272A1PendingUtilityA1
Ethanamine Compounds and Methods of Using the Same
Est. expiryDec 24, 2028(~2.5 yrs left)· nominal 20-yr term from priority
Inventors:Michael BalestraPeter BernsteinGlen ErnstWilliam FrietzeJohn MccauleyLihong ShenDavid Nugiel
A61P 25/24A61P 25/08A61P 25/04A61P 25/16A61P 25/00A61K 31/4402C07D 213/38C07C 57/15C07D 213/36
49
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
(S)-2-methyl- 1 -phenyl-2-(pyridin-2-yl)propan-1-amine, pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising the same, uses of said compound or salt for therapy of depression and other conditions, and methods of treating depression and other conditions by administering said compound or salt.
Claims
exact text as granted — not AI-modified1 . A compound that is (S)-2-methyl-1-phenyl-2-(pyridin-2-yl)propan-1-amine having the following structure:
or a pharmaceutically acceptable salt thereof.
2 . Use of a compound or a pharmaceutically acceptable salt thereof according to claim 1 for the treatment of depression.
4 . Use of a compound or a pharmaceutically acceptable salt thereof according to claim 1 is the preparation of a medicament for the treatment of depression
5 . A method of treating depression in a in a human which comprises administering to a person in need thereof a therapeutically effective amount of a compound or a pharmaceutically acceptable salt thereof according to claim 1 .
6 . A pharmaceutical composition comprising a compound or pharmaceutically acceptable salt thereof according to claim 1 and at least one pharmaceutically acceptable excipient, diluent or carrier.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.